Remotely Monitored ICDs Propel Medtronic’s 6% Market Share Gain
This article was originally published in The Gray Sheet
Executive Summary
Expanding availability and increasing market acceptance of Medtronic's Virtuoso ICD and Concerto cardiac resynchronization therapy product drove a 14% sequential quarterly advance in defibrillator sales, allowing the company to capture market share